Vaginal Myomectomy for Semipedunculated Cervical Myoma during Pregnancy

por Obara, Mikitaka, Hatakeyama, Yuko, Shimizu, Yasushi
Publicado 2014

Crystalline silica-exposed human lung epithelial cells presented enhanced anchorage-independent growth with upregulated expression of BRD4 and EZH2 in autocrine and paracrine manne...

por Katabami, Motoo, Kinoshita, Ichiro, Ariga, Shin, Shimizu, Yasushi, Dosaka-Akita, Hirotoshi
Publicado 2023

Role of targeted therapy in metastatic colorectal cancer

por Ohhara, Yoshihito, Fukuda, Naoki, Takeuchi, Satoshi, Honma, Rio, Shimizu, Yasushi, Kinoshita, Ichiro, Dosaka-Akita, Hirotoshi
Publicado 2016

Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors

por Takeda, Kayoko, Kinoshita, Ichiro, Shimizu, Yasushi, Ohba, Yusuke, Itoh, Tomoo, Matsuno, Yoshihiro, Shichinohe, Toshiaki, Dosaka-Akita, Hirotoshi
Publicado 2008

Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells

por Takashina, Taichi, Kinoshita, Ichiro, Kikuchi, Junko, Shimizu, Yasushi, Sakakibara‐Konishi, Jun, Oizumi, Satoshi, Nishimura, Masaharu, Dosaka‐Akita, Hirotoshi
Publicado 2016

Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis

por Saito, Yoshitaka, Sakamoto, Tatsuhiko, Takekuma, Yoh, Kobayashi, Masaki, Okamoto, Keisuke, Shinagawa, Naofumi, Shimizu, Yasushi, Kinoshita, Ichiro, Sugawara, Mitsuru
Publicado 2022

A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy

por Takeuchi, Satoshi, Honma, Rio, Taguchi, Jun, Amano, Toraji, Shimizu, Yasushi, Kinoshita, Ichiro, Kubota, Kanako, Matsuno, Yoshihiro, Dosaka-Akita, Hirotoshi
Publicado 2011

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment

por Saito, Yoshitaka, Tamaki, Shinya, Hirate, Daisuke, Takada, Shinya, Takahashi, Kenta, Takekuma, Yoh, Sakakibara-Konishi, Jun, Shimizu, Yasushi, Kinoshita, Ichiro, Sugawara, Mitsuru
Publicado 2023

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients

por Saito, Yoshitaka, Kobayashi, Masaki, Tamaki, Shinya, Nakamura, Katsuyuki, Hirate, Daisuke, Takahashi, Kenta, Takekuma, Yoh, Sakakibara-Konishi, Jun, Shimizu, Yasushi, Kinoshita, Ichiro, Sugawara, Mitsuru
Publicado 2023

Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer

por Ohhara, Yoshihito, Kinoshita, Ichiro, Suzuki, Akira, Imagawa, Makoto, Taguchi, Jun, Noguchi, Takuro, Takeuchi, Satoshi, Shimizu, Yasushi, Seki, Hideyuki, Suzuki, Junichi, Dosaka-Akita, Hirotoshi
Publicado 2022

Late Onset of Non-islet Cell Tumor Hypoglycemia Managed via Multidisciplinary Treatment in a Patient with a Solitary Fibrous Tumor

por Takeuchi, Satoshi, Goda, Tomohiro, Taguchi, Jun, Douhata, Yuichi, Honma, Rio, Ariga, Shin, Ohhara, Yoshihito, Shimizu, Yasushi, Kinoshita, Ichiro, Fukuda, Izumi, Nagashima, Yoji, Akita, Hirotoshi
Publicado 2018

EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment

por Shiiya, Akihiko, Noguchi, Takuro, Tomaru, Utano, Ariga, Shin, Takashima, Yuta, Ohhara, Yoshihito, Taguchi, Jun, Takeuchi, Satoshi, Shimizu, Yasushi, Kinoshita, Ichiro, Koizumi, Tomonobu, Matsuno, Yoshihiro, Shinagawa, Naofumi, Sakakibara‐Konishi, Jun, Dosaka‐Akita, Hirotoshi
Publicado 2022

Early prediction of lenvatinib treatment efficacy by using (18)F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment:...

por Takeuchi, Satoshi, Shiga, Tohru, Hirata, Kenji, Taguchi, Jun, Magota, Keiichi, Ariga, Shin, Gouda, Tomohiro, Ohhara, Yoshihito, Homma, Rio, Shimizu, Yasushi, Kinoshita, Ichiro, Tsuji, Yasushi, Homma, Akihiro, Iijima, Hiroaki, Tamaki, Nagara, Dosaka-Akita, Hirotoshi
Publicado 2018

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the h...

por Enokida, Tomohiro, Ogawa, Takenori, Homma, Akihiro, Okami, Kenji, Minami, Shujiro, Nakanome, Ayako, Shimizu, Yasushi, Maki, Daisuke, Ueda, Yuri, Fujisawa, Takao, Motegi, Atsushi, Ohkoshi, Akira, Taguchi, Jun, Ebisumoto, Koji, Nomura, Shogo, Okano, Susumu, Tahara, Makoto
Publicado 2020

Early prediction of treatment outcome for lenvatinib using (18)F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prosp...

por Takeuchi, Satoshi, Hirata, Kenji, Magota, Keiichi, Watanabe, Shiro, Moku, Rika, Shiiya, Akihiko, Taguchi, Jun, Ariga, Shin, Goda, Tomohiro, Ohhara, Yoshihito, Noguchi, Takurou, Shimizu, Yasushi, Kinoshita, Ichiro, Honma, Rio, Tsuji, Yasushi, Homma, Akihiro, Dosaka-Akita, Hirotoshi
Publicado 2023

Two‐year follow‐up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell...

por Yen, Chia‐Jui, Kiyota, Naomi, Hanai, Nobuhiro, Takahashi, Shunji, Yokota, Tomoya, Iwae, Shigemichi, Shimizu, Yasushi, Hong, Ruey‐Long, Goto, Masahiro, Kang, Jin‐Hyoung, Li, Wing Sum Kenneth, Ferris, Robert L., Gillison, Maura, Endo, Toshimitsu, Jayaprakash, Vijayvel, Tahara, Makoto
Publicado 2020

A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPIT...

por Takahashi, Kenta, Ishibashi, Eri, Kubo, Toshio, Harada, Yohei, Hayashi, Hideyuki, Kano, Masayuki, Shimizu, Yasushi, Shirota, Hidekazu, Mori, Yukiko, Muto, Manabu, Ishioka, Chikashi, Dosaka-Akita, Hirotoshi, Matsubara, Hisahiro, Nishihara, Hiroshi, Sueoka-Aragane, Naoko, Toyooka, Shinichi, Hirakawa, Akihiro, Tateishi, Ukihide, Miyake, Satoshi, Ikeda, Sadakatsu
Publicado 2020

First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048

por Takahashi, Shunji, Oridate, Nobuhiko, Tanaka, Kaoru, Shimizu, Yasushi, Fujimoto, Yasushi, Matsumoto, Koji, Yokota, Tomoya, Yamazaki, Tomoko, Takahashi, Masanobu, Ueda, Tsutomu, Hanai, Nobuhiro, Yamaguchi, Hironori, Hara, Hiroki, Yoshizaki, Tomokazu, Yasumatsu, Ryuji, Nakayama, Masahiro, Shiga, Kiyoto, Fujii, Takashi, Mitsugi, Kenji, Takahashi, Kenichi, Nohata, Nijiro, Gumuscu, Burak, Swaby, Ramona F., Tahara, Makato
Publicado 2022

Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study

por Hanai, Nobuhiro, Shimizu, Yasushi, Kariya, Shin, Yasumatsu, Ryuji, Yokota, Tomoya, Fujii, Takashi, Tsukahara, Kiyoaki, Yoshida, Masafumi, Hanyu, Kenji, Ueda, Tsutomu, Hirakawa, Hitoshi, Takahashi, Shunji, Ono, Takeharu, Sano, Daisuke, Yamauchi, Moriyasu, Watanabe, Akihito, Omori, Koichi, Yamazaki, Tomoko, Monden, Nobuya, Kudo, Naomi, Arai, Makoto, Sakurai, Daiju, Asakage, Takahiro, Doi, Issei, Yamada, Takayuki, Homma, Akihiro
Publicado 2020

Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real‑world clinical practice: a multicentre retrospective clinical study

por Hanai, Nobuhiro, Shimizu, Yasushi, Kariya, Shin, Yasumatsu, Ryuji, Yokota, Tomoya, Fujii, Takashi, Tsukahara, Kiyoaki, Yoshida, Masafumi, Hanyu, Kenji, Ueda, Tsutomu, Hirakawa, Hitoshi, Takahashi, Shunji, Ono, Takeharu, Sano, Daisuke, Yamauchi, Moriyasu, Watanabe, Akihito, Omori, Koichi, Yamazaki, Tomoko, Monden, Nobuya, Kudo, Naomi, Arai, Makoto, Sakurai, Daiju, Asakage, Takahiro, Doi, Issei, Yamada, Takayuki, Homma, Akihiro
Publicado 2021